Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213648 · ClinicalTrials.gov registry record · NA
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
A NA study of Parkinson Disease and Huntington Disease, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 1
- Study location
NCT07213648 is a NA study of Parkinson Disease and Huntington Disease that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 136 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07213648, a NA study of Parkinson Disease and Huntington Disease, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess preliminary efficacy of a tailored cognitive bias modification for interpretation (CBM-I) app for reducing anxiety in Huntington's disease and Parkinson's disease.
Conditions Studied
Interventions
- BEHAVIORAL MindTrails-Movement
- OTHER Waitlist Control
Study Locations (1)
Virginia
- Univeristy of Virginia School of Nursing - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2025-11-20 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07213648
The ClinicalTrials.gov registry entry for NCT07213648 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (97% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which MindTrails-Movement is the first listed.
NCT07213648 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT07213648 about?
NCT07213648 is a clinical study titled "Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)". The purpose of this study is to assess preliminary efficacy of a tailored cognitive bias modification for interpretation (CBM-I) app for reducing anxiety in Huntington's disease and Parkinson's disease.
What is the current status of trial NCT07213648?
This trial is currently recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2025-11-20. Estimated completion is 2026-09.
What conditions does trial NCT07213648 study?
This clinical trial studies the following conditions: Parkinson Disease, Huntington Disease.
What interventions are being tested in trial NCT07213648?
The interventions under investigation include: MindTrails-Movement (BEHAVIORAL), Waitlist Control (OTHER).
Who is sponsoring clinical trial NCT07213648?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213648 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
-
Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.